Filing Details

Accession Number:
0001209191-17-037907
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-06-05 17:56:57
Reporting Period:
2017-06-01
Filing Date:
2017-06-05
Accepted Time:
2017-06-05 17:56:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1334365 Yuchun Lee C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-06-01 2,188 $0.00 6,170 No 4 A Direct
Common Stock Disposition 2017-06-02 1,323 $128.44 4,847 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2017-06-01 5,295 $0.00 5,295 $125.71
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,295 2027-05-31 No 4 M Direct
Footnotes
  1. Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.
  2. Transaction made pursuant to Mr. Yuchun's company approved trading plan under Rule 10b5-1.
  3. Fully vested.